High prevalence of three prothrombotic polymorphisms among Palestinians: Factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 3, 2012, Pages 383-387

  Hussein, Ayman S ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Allelic frequency; Factor V leiden mutation; MTHFR; Palestine; Prothrombin; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOSINE; GLYCINE; PROTHROMBIN; THYMINE;

ADULT; AGE; ARAB; ARTICLE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; INTERVIEW; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDENTIAL AREA; SEX DIFFERENCE; SMOKING HABIT; THROMBOEMBOLISM; UNIVERSITY STUDENT;

ADULT; AMINO ACID SUBSTITUTION; ARABS; FACTOR V; FEMALE; HUMANS; ISRAEL; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; QUESTIONNAIRES; VENOUS THROMBOEMBOLISM;

EID: 84868497603     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0731-9     Document Type: Article

References (29)

1. Dahlbäck B (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19-27
2. Walker JD (2000) Thrombophilia in pregnancy. J Clin Pathol 53(8):570-573
3. Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
4. Finan R, Tamim H, Ameen G et al (2002) Prevalence of factor VG1691A (factor V-leiden) and prothrombin gene mutations in a recurrent miscarriage population. Am J Hematol 71:300-305
5. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343(14):1015-1018
6. Isotalo PA, Wells GA, Donnelly JG (2000) Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67(4):986-990
7. Lensen R, Rosendaal F, Vandenbroucke J, Bertina R (2000) Factor V leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol 110(4):939-945
8. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JL (2008) Thrombophilias and adverse pregnancy outcome - a confounded problem. Thromb Haemostat 99(1):77-85
9. Dahlbäck B (1997) Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 34(3): 217-234
10. Khan S, Dickerman JD (2006) Hereditary thrombophilia Thromb J 4:15
11. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V leiden. Lancet 346(8983):1133-1134
12. Koksal V, Baris I, Etlik O (2007) Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations. Exp Mol Pathol 83(1):1-3
13. Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J (2009) Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 373(9668): 1041-1049
14. Hussein AS, Darwish H, Shelbayeh K (2010) Association between factor V leiden mutation and poor pregnancy outcomes among Palestinian women. Thromb Res 126(2):e78-82
15. Bathelier C, Champenois T, Lucotte G (1998) ARMS test for diagnosis of factor V leiden mutation and allele frequencies in France. Mol Cell Probes 12:121-123
16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10): 3698-3703
17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111-113
18. Kark JD, Fink R, Adler B, Goldberger N, Goldman S (2006) The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int J Epidemiol 35(2):448-457
19. Cleary-Goldman J, Nakhuda GS, Zimmermann RC, Sauer MV (2003) The role of factor V leiden mutation in recurrent pregnancy loss. J Am Med Womens Assoc 58(3):165-172
20. Ozmen F, Ozmen MM, Ozalp N, Akar N (2009) The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 15(2):113-119
21. Dashti AA, Jadaon MM, Abdulsamad AM, Dashti MH, Lewis HL (2011) Thrombosis risk in carriers of the factor V leiden mutation: is it associated with a defined skin color? Pathol Res Pract 207(11):671-673
22. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis 20(3): 163-168
23. Dashti AA, Jadaon MM (2011) Race differences in the prevalence of the factor V leiden mutation in Kuwaiti nationals. Mol Biol Rep 38(6):3623-3628
24. Eid SS, Rihani G (2004) Prevalence of factor V leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 17(4):200-202
25. Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M (2007) Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Neuro Endocrinol Lett 28(5):699-703
26. Rosen E, Renbaum P, Heyd J, Levy-Lahad E (1999) High frequency of factor V leiden in a population of Israeli Arabs. Thromb Haemostat 82(6):1768
27. Settin A, Dowaidar M, El-Baz R, Abd-Al-Samad A, El-Sayed I, Nasr M (2008) Frequency of factor V leiden mutation in Egyptian cases with myocardial infarction. Hematology 13(3):170-174
28. Akar N, Misirlioǧlu M, Akar E, Avcu F, Yalçin A, Sözüöz A (1998) Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 58(3):249
29. Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N (2004) Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 76(1):85-87